Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$36,283,680
-$10,219,770 QoQ
Shares Held
999,000
0.0% QoQ
Ownership
0.947%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Derivatives in CRNX
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$4,165,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. CRNX ranks #24 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $488,832,498 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
7,959,538 | $312,013,889 | |
| 3 | SION |
Sionna Therapeutics, Inc.
|
3,530,702 | $141,545,843 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
3,637,887 | $108,590,926 | |
| 5 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $104,824,037 | |
| 6 | ARGX |
Argenx SE
|
136,900 | $99,971,225 | |
| 7 | CMPX |
Compass Therapeutics, Inc.
|
15,219,994 | $80,513,768 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,475,403 | $71,114,424 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,283,680 | 999,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $46,503,450 | 999,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,165,000 | 100,000 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $45,773,350 | 1,099,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $33,045,240 | 1,149,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $33,506,460 | 999,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $51,078,870 | 999,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $53,657,810 | 1,050,055 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $57,367,032 | 1,280,800 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $64,831,850 | 1,385,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $59,324,668 | 1,667,360 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $86,129,240 | 2,896,074 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $71,193,343 | 3,950,796 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $63,449,783 | 3,950,796 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $58,502,830 | 3,196,876 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $62,786,644 | 3,196,876 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $59,621,737 | 3,196,876 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $70,171,428 | 3,196,876 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $90,823,247 | 3,196,876 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $63,084,239 | 2,996,876 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $56,491,112 | 2,996,876 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $42,074,503 | 2,753,567 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $38,852,830 | 2,753,567 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $43,148,394 | 2,753,567 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $48,242,493 | 2,753,567 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $29,977,445 | 2,039,282 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||